Cargando…
A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern
As SARS-CoV-2 variants of concern (VoCs) that evade immunity continue to emerge, next-generation adaptable COVID-19 vaccines which protect the respiratory tract and provide broader, more effective, and durable protection are urgently needed. Here, we have developed one such approach, a highly effica...
Autores principales: | Xu, Jiayu, Zhang, Yuexiu, Qu, Panke, Shamseldin, Mohamed M., Yoo, Sung J., Misny, Jack, Thongpan, Ilada, KC, Mahesh, Hall, Jesse M., Evans, John P., Eltobgy, Mostafa, Lu, Mijia, Ye, Chengjin, Chamblee, Michelle, Liang, Xueya, Martinez-Sobrido, Luis, Amer, Amal O., Yount, Jacob S., Boyaka, Prosper N., Peeples, Mark E., Liu, Shan-Lu, Dubey, Purnima, Li, Jianrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576135/ https://www.ncbi.nlm.nih.gov/pubmed/37796985 http://dx.doi.org/10.1073/pnas.2220403120 |
Ejemplares similares
-
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
por: Lu, Mijia, et al.
Publicado: (2022) -
A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike
por: Zhang, Yuexiu, et al.
Publicado: (2022) -
A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters
por: Lu, Mijia, et al.
Publicado: (2021) -
A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike
por: Lu, Mijia, et al.
Publicado: (2021) -
5-methylcytosine (m(5)C) RNA modification controls the innate immune response to virus infection by regulating type I interferons
por: Zhang, Yuexiu, et al.
Publicado: (2022)